Tryp Barcelona Apolo Hotel
Av. del Paral.lel 57-59, 08004
Due to the nature of Pharma/Biotech R&D, it is a costly, time-consuming affair, notwithstanding the ever-growing competition and fluctuating environments. Developing drug portfolios demands PPM to be highly innovative, structured and well organised.
Vonlanthen Group of Companies shall be hosting an event to overcome these challenges, through an expert panel of speakers and delegates to discuss, innovate and resolve critical issues for fast track solutions to complex PPM problems.
Key Practical Learning Points of the Summit:
Who Should Attend:
Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:
Christoph Kalis Associate Director PMO Novartis
Dr. Simon Preston Global Regulatory Affairs, Patient Safety and Quality Assurance AstraZeneca
Dr. Dorothee Breuer-Giersiepen Director Clinical Project Management, Real-World Evidence Solutions QuintilesIMS
Sigrún Stefánsdóttir Director Strategic Launch Management & PMO Actavis - a Teva company
Alexis Poulet Global Head of R&D Finance & Controlling Ferring Pharmaceuticals
Kamil Mroz Managing Director CENPREX Sprl
David Carrasco Strategic Operations Director, Real-World Evidence Solutions QuintilesIMS
Dr. Kenny Blades Director, Global Program Management DOCS / ICON ICON PLC
Anna Aillerie Director - Commercial Biosimilars EMEA Lupin
Frank Berger Head, Study Budget CoE, Global Clinical Operations Boehringer Ingelheim
Dr. Donatienne Phillips Business Director - Early Development Covance
Denise Moody Senior Director Project Management FSP PPD
To request an agenda for this Summit, please complete the details below. We will send an agenda to you via email.
To buy a documentation package for this Summit, please complete the details below. Upon receiving this form we will send an invoice for the documentation package. The cost for the documentation package is €500. Upon successfully receiving payment, we will send you the documentation package.